Rivaroxaban

Global Calcium is one of the leading manufacturers and exporters of Rivaroxaban CAS no. 366789-02-8, API, (Active Pharmaceutical Ingredient). We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, Global Calcium has stood the test of time since its inception in 1979.

As manufacturer of Rivaroxaban we hereby state the following facts about the drug:

Rivaroxaban API is typically used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE), which are serious conditions that can occur when blood clots form in the legs or lungs. It is also used to prevent stroke and systemic embolism in patients with nonvalvular atrial fibrillation, a condition in which the heart beats irregularly and can increase the risk of blood clots. Rivaroxaban API can also be used to treat DVT and PE after surgery.

Mechanism of action:

Rivaroxaban API is a direct factor Xa inhibitor. Factor Xa is a protein involved in the clotting cascade. By blocking the activity of factor Xa, rivaroxaban API prevents the formation of blood clots.

Rivaroxaban API is a highly selective factor Xa inhibitor. It has a much higher affinity for factor Xa than for other proteins in the clotting cascade. This selectivity makes rivaroxaban API a safe and effective anticoagulant.

Global Calcium is a leading manufacturer of this drug. We manufacture this pharmaceutical drug and make it available to domestic and overseas market